Risk factors for increased multiple sclerosis susceptibility in the Iranian population

Journal of Clinical Neuroscience

Volumn 21, Issue 12, 2014, Pages 2207-2211

  Mansouri, Behnam ^a   Asadollahi, Shadi ^b   Heidari, Kamran ^c   Fakhri, Mohammad ^b   Assarzadegan, Farhad ^a   Nazari, Maryam ^a   Divani, Afshin ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Allergy; Autoimmune disease; Brain injury; Case control; Iran; Multiple sclerosis; Risk factor

Indexed keywords

ADULT; ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; HUMAN; IRANIAN PEOPLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SMOKING; SUN EXPOSURE; ENVIRONMENTAL EXPOSURE; HYPERSENSITIVITY; IRAN; SUNLIGHT;

ADULT; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYPERSENSITIVITY; IRAN; MALE; MULTIPLE SCLEROSIS; RISK FACTORS; SMOKING; SUNLIGHT;

EID: 84922805649     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2014.04.020     Document Type: Article

References (46)

1. Paty DW, Ebers G. Multiple sclerosis. Philadelphia, FA: Davis Company; 1998.
2. Handel AE, Giovannoni G, Ebers GC, et al. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010;6:156-66.
3. Casetta I, Granieri E. Prognosis of multiple sclerosis: environmental factors. Neurol Sci 2000;21:S839-42.
4. Warren SA, Svenson LW, Warren KG. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler 2008;14:872-9.
5. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129-35.
6. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: an overview. Neurology 1980;30:61-79.
7. Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011;17:1022-7.
8. Etemadifar M, Janghorbani M, Shaygannejad V, et al. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006;27:39-44.
9. Alonso A, Cook SD, Maghzi AH, et al. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011;17:550-5.
10. Saadatnia M, Etemadifar M, Maghzi AH. Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007;79:357-75.
11. Elhami SR, Mohammad K, Sahraian MA, et al. A 20-year incidence trend (1989- 2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011;36:141-7.
12. Declaration of Helsinki: ethical principles for medical research involving human subjects. Seoul, Korea: World Medical Association, 2008. Available from: http://www.wma.net/en/30publications/10policies/b3/.
13. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
14. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Ann Neurol 2005;58: 840-6.
15. Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 2007;13:610-5.
16. Handel AE, Williamson AJ, Disanto G, et al. Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 2011;6:e16149.
17. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
18. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010;9:A387-94.
19. Barcellos LF, Kamdar BB, Ramsay PP, et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006;5:924-31.
20. Ramagopalan SV, Dobson R, Meier UC, et al. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010;9:727-39.
21. Mandel M, Gurevich M, Pauzner R, et al. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin Exp Immunol 2004;138: 164-70.
22. Maas K, Chan S, Parker J, et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002;169:5-9.
23. Maas K, Chen H, Shyr Y, et al. Shared gene expression profiles in individuals with autoimmune disease and unaffected first-degree relatives of individuals with autoimmune diseases. Hum Mol Genet 2005;14:1305-14.
24. Somers EC, Thomas SL, Smeeth L, et al. Autoimmune diseases co-occurring within individuals and within families. A systematic review. Epidemiology 2006;17:202-17.
25. Midgard R, Grønning M, Riise T, et al. Multiple sclerosis and chronic inflammatory diseases. A case-control study. Acta Neurol Scand 1996;93: 322-8.
26. Heinzlef O, Alamowitch S, Sazdovitch V, et al. Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand 2000;101:36-40.
27. Broadley SA, Deans J, Sawcer SJ, et al. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. Brain 2000;123:1102-11.
28. Marrosu MG, Cocco E, Lai M, et al. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet 2002;359: 1461-5.
29. Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005;129: 819-26.
30. Alonso A, Jick SS, Hernán MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 2006;66:572-5.
31. Dimitriadou V, Pang X, Theoharides TC. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int J Immunopharmacol 2000;22:673-84.
32. Pedotti R, Mitchell D, Wedemeyer J, et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat Immunol 2001;2: 216-22.
33. Pedotti R, De Voss JJ, Steinman L, et al. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 2003;24:479-84.
34. Pfleger CC, Koch-Henriksen N, Stenager E, et al. Head injury is not a risk factor for multiple sclerosis: a prospective cohort study. Mult Scler 2009;15:294-8.
35. Goldacre MJ, Abisgold JD, Yeates DG, et al. Risk of multiple sclerosis after head injury: record linkage study. J Neurol Neurosurg Psychiatry 2006;77:351-3.
36. US Department of Health and Human Services. Types of injuries and impairments due to injuries. National Health Survey 1986; Series 10; (PHS)159: 8-26.
37. Zorzon M, Zivadinov R, Nasuelli D, et al. Risk factors of multiple sclerosis: a case-control study. Neurol Sci 2003;24:242-7.
38. Moshe T, Shoenfeld Y. Vaccines and autoimmunity. In: Rose Noel R, Mackay Ian R, editors. The autoimmune diseases. Amsterdam: Elsevier; 2006. p. 309-16.
39. DeStefano F, Verstraten T, Jackson LA, et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003;60:504-9.
40. Casetta I, Granieri E, Malagù S, et al. Environmental risk factors and multiple sclerosis: a community based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994;13:120-8.
41. Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 2011;258:1197-206.
42. Alter M, Speer J. Clinical evaluation of possible etiologic factors in multiple sclerosis. Neurology 1968;18:109-16.
43. Hopkins RS, Indian RW, Pinnow E, et al. Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 1991;10: 192-9.
44. Kurtzke JF, Hyllested K, Arbuckel JD, et al. Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurol Scand 1997;96:149-57.
45. Srivastava K. Urbanization and mental health. Ind Psychiatry J 2009;18:75-6.
46. Guzel R, Kozanoglu E, Guler-Uysal F, et al. Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med 2001;10:765-70.